Dr. Craig J. Badolato, MD

Dr. Badolato practices at Cancer Care Centers of Brevard Inc in Melbourne, Florida.

Dr. Badolato's NPI, 1013998970, was assigned on November 8, 2005. Dr. Badolato graduated from Drexel University College Of Medicine in 1986. Dr. Badolato holds Florida license ME61815.

Dr. Badolato's primary practice is Cancer Care Centers of Brevard Inc, at 1430 Pine St, Melbourne, FL 32901 in Brevard County. The practice phone is (321) 952-0898.

Dr. Badolato's primary practice is Cancer Care Centers of Brevard Inc in Melbourne, Florida. Dr. Badolato is also affiliated with Holmes Regional Medical Center. The medical group on file is Cancer Care Centers of Brevard. Dmand AI also links Dr. Badolato to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Badolato practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Badolato's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Badolato is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Badolato's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Badolato treats.

CMS data shows 12,625 Medicare services from Dr. Badolato across 16 procedure codes in 2024, for 381 Medicare patients. Medicare paid $315,112 for them.

CMS counts 381 Medicare patients who saw Dr. Badolato in 2024. The largest group is 75 to 84, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Badolato's median patient age at 69, with 59% women.

In 2024, Dr. Badolato wrote 1,402 Medicare Part D claims for 208 patients. 79% of them were for generic drugs. CMS names the drug for 1,153 of them, across 36 drugs with 11 or more claims each, at $3,276,928 in total drug cost. In 2023, CMS named 981 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Badolato for performance year 2024, reported individually. Dr. Badolato accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Badolato in 2025. Dr. Badolato's most frequent co-authors are Bryce Alden Baird, MD and Timothy David Lyon, MD.

CMS Open Payments shows 2,254 general payments to Dr. Badolato from 111 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,549.

Dmand AI lists 1 award for Dr. Badolato, most recently CMS Stage 1 EHR in 2013.

Dr. Badolato graduated from Drexel University College Of Medicine in 1986.

Dr. Badolato is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.